MasterMetals on Twitter

April 17, 2015

Midatech Pharma’s OpsiSporin showing ‘exceedingly good promise’ – CEO

Jim Phillips, chief executive of Midatech Pharma (LON:MTPH), says eye-disease drug OpsiSporin is on an accelerated programme in terms of investment priorities after it showed ‘exceedingly good...

[[ This is a content summary only. Visit my website for full links, other content, and more! ]] @MasterMetals MasterMetals Blog

No comments:

Post a Comment

Commented on The MasterMetals BlogThe MasterMetals Blog